These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17714062)

  • 1. The use of TNF-alpha blocking agents in rheumatoid arthritis: an update.
    Toussirot E; Wendling D
    Expert Opin Pharmacother; 2007 Sep; 8(13):2089-107. PubMed ID: 17714062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview.
    Toussirot E; Wendling D
    Expert Opin Pharmacother; 2004 Mar; 5(3):581-94. PubMed ID: 15013927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease.
    Shanahan JC; St Clair W
    Clin Immunol; 2002 Jun; 103(3 Pt 1):231-42. PubMed ID: 12173297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of breast cancer and total malignancies in rheumatoid arthritis patients undergoing TNF-α antagonist therapy: a meta-analysis of randomized control trials.
    Liu Y; Fan W; Chen H; Yu MX
    Asian Pac J Cancer Prev; 2014; 15(8):3403-10. PubMed ID: 24870729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.
    Moreland LW
    Pharmacoeconomics; 2004; 22(2 Suppl 1):39-53. PubMed ID: 15157003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experience.
    Richard-Miceli C; Dougados M
    BioDrugs; 2001; 15(4):251-9. PubMed ID: 11437690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab for rheumatoid arthritis.
    Voulgari PV; Drosos AA
    Expert Opin Biol Ther; 2006 Dec; 6(12):1349-60. PubMed ID: 17223742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis.
    Keystone EC
    Rheum Dis Clin North Am; 2001 May; 27(2):427-43. PubMed ID: 11396102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years of infliximab: insights from clinical trials in rheumatoid arthritis.
    Smolen JS
    Eur J Pharmacol; 2009 Nov; 623 Suppl 1():S5-9. PubMed ID: 19843471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of anti-TNF therapy in rheumatoid arthritis].
    Meyer O
    Presse Med; 2000 Mar; 29(9):463-8. PubMed ID: 10745935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
    Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
    Koike R; Takeuchi T; Eguchi K; Miyasaka N;
    Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis.
    Inanc N; Direskeneli H
    Rheumatol Int; 2006 Nov; 27(1):67-71. PubMed ID: 16896990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
    Li N; Betts KA; Messali AJ; Skup M; Garg V
    Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
    Bongartz T; Sutton AJ; Sweeting MJ; Buchan I; Matteson EL; Montori V
    JAMA; 2006 May; 295(19):2275-85. PubMed ID: 16705109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.
    Mitoma H; Horiuchi T; Tsukamoto H; Ueda N
    Cytokine; 2018 Jan; 101():56-63. PubMed ID: 27567553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.